Here is a collection of studies and articles that I have gathered while researching the HPV vaccine. I will continue to update and add to this page as I learn more and as more research is published.
Autoantibodies against Autonomic Nerve Receptors in Adolescent Japanese Girls after Immunization with Human Papillomavirus Vaccine
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl
Bivalent HPV vaccine safety depending on subtypes of juvenile idiopathic arthritis
A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase® (2017)
Fibromyalgia-Like Illness in 2 Girls After Human Papillomavirus Vaccination
Erythema multiforme following vaccination for human papillomavirus
Human papillomavirus vaccine and systemic lupus erythematosus
Human papilloma virus vaccine associated uveitis
Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction - a review of the regulatory evidence from the European Medicines Agency
Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80
Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study
Hypothesis: Human papillomavirus vaccination syndrome--small fiber neuropathy and dysautonomia could be its underlying pathogenesis
Immune thrombocytopenic purpura following human papillomavirus vaccination
Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis
Lichenoid Drug Eruption After Human Papillomavirus Vaccination
Postural tachycardia syndrome following human papillomavirus vaccination
Severe manifestations of autoimmune syndrome induced by adjuvants (Shoenfeld's syndrome).
Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women
No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?
Telogen effluvium following bivalent human papillomavirus vaccine administration: a report of two cases
Adverse events following HPV vaccination, Alberta 2006-2014
HPV vaccination syndrome. A questionnaire-based study
Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
Autonomic dysfunction and HPV immunization: An overview.
Current safety concerns with human papillomavirus vaccine: A cluster analysis of reports in VigiBase
Japanese Focal Inflammation Research Group Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines
Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report
Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil
Brachial plexus neuritis following HPV vaccination
CNS demyelination and quadrivalent HPV vaccination
Demyelinating disease and polyvalent human papilloma virus vaccination
Demyelinating disease and vaccination of the human papillomavirus
Neurologic Complications in HPV Vaccination
Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine
Small Fiber Neuropathy Following Vaccination
Syncope and seizures following human papillomavirus vaccination: a retrospective case series
Two Cases of Acute Disseminated Encephalomyelitis Following Vaccination Against Human Papilloma Virus
Excess Teen Suicide Risk Associated with Gardasil Exposure: Implications for Public Health Policy
Ampiginous choroiditis following quadrivalent human papilloma virus vaccine
Panuveitis With Exudative Retinal Detachments After Vaccination Against Human Papilloma Virus
A 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus
Psychiatric conditions and general practitioner attendance prior to HPV vaccination and the risk of referral to a specialized hospital setting because of suspected adverse events following HPV vaccination: A register-based, matched case-control study.
American College of Pediatrics warns of ovarian failure linked to the HPV (Gardasil) cervical cancer vaccine
Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice
Human papilloma virus vaccine and primary ovarian failure: another facet of the autoimmune/inflammatory syndrome induced by adjuvants.
A link between human papilloma virus vaccination and primary ovarian insufficiency: current analysis
Premature ovarian failure 3 years after menarche in a 16-year-old girl following human papillomavirus vaccination
A lowered probability of pregnancy in females in the USA aged 25–29 who received a human papillomavirus vaccine injection
Cervical cancers after human papillomavirus vaccination
Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination
HPV-negative Gastric Type Adenocarcinoma In Situ of the Cervix: A Spectrum of Rare Lesions Exhibiting Gastric and Intestinal Differentiation
Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Death after Quadrivalent Human Papillomavirus (HPV) Vaccination: Causal or Coincidental?
Potential cross-reactivity between HPV16 L1 protein and sudden death-associated antigens
Two unclear cases of death. Can we still recommend HPV vaccination?
Safety, Efficacy, Conflicts of Interest, and More
Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Human Papillomavirus Vaccination
Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds?
Too fast or not too fast: the FDA's approval of Merck's HPV vaccine Gardasil
Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial
HPV vaccines and cancer prevention, science versus activism
Who Profits From Uncritical Acceptance of Biased Estimates of Vaccine Efficacy and Safety?
Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology
Discrepancies in the evaluation of the safety of the human papillomavirus vaccine
HPV vaccination discourses and the construction of “at-risk” girls
HPV vaccines – A review of the first decade
Around the world
Japanese medical experts issue warning against HPV cervical cancer vaccine
Japan de-recommended Gardasil three months after it had added the vaccine to the immunization schedule.
Lessons learnt in Japan from adverse reactions to the HPV vaccine: a medical ethics perspective
800 girls in Carmen de Bolivar grievously injured by the Gardasil vaccine
Protests erupt in Columbia over HPV vaccine injuries
Colombia’s highest Constitutional Court ruled that the HPV vaccine would no longer be considered mandatory in Colombia and ordered that girls who showed symptoms after receiving the vaccine be given appropriate medical care.
Denmark Documentary exposing the deaths and permanent injuries of young women after receiving the HPV Vaccine
Denmark announced the opening of five new HPV clinics to treat women who were injured by the Gardasil vaccine
Parents in Ireland form the group REGRET about the HPV vaccine
Thousands of parents of HPV Vaccine injured children in the UK form the group Sanevax
Alleged Irregularities in the Conduct of Studies using Human Papilloma Virus (HPV) Vaccine by Path in India (Department of Health Research, Ministry of Health and Family Welfare)